Mycobacterioses identified in the National Reference Laboratory of Colombia from 2012 to 2016

Claudia Llerena, Angélica Valbuena, Angie Paola Zabaleta, .

Keywords: Mycobacterium, non-tuberculous mycobacteria, risk factors, coinfection, opportunistic infections, Colombia

Abstract

Introduction: In recent years, there has been an increase in the prevalence of mycobacterioses caused by non-tuberculous mycobacteria, which are considered as emerging pathogens. Their presence depends on several factors such as the clinical history, the health status of the affected person, and the presence of these microorganisms in the water, the soil, and the animals, among others.
Objective: To describe the mycobacteria and the etiological agent identified in isolates received at the Laboratorio Nacional de Referencia de Micobacterias of the Instituto Nacional de Salud between 2012 and 2016.
Materials and methods: We conducted a retrospective analysis of samples from 273 patients with mycobacterioses. We analyzed the following variables: mycobacteriosis type, etiological agent, and associated predisposing factors.
Results: 57.1% of the cases presented pulmonary mycobacteriosis; 26%, cutaneous; 10.6%, disseminated, and 2.6%, lymphatic. We found the Mycobacterium avium complex more frequently in pulmonary mycobacteriosis, while M. abscessus was more frequent in the extrapulmonary types of the disease. Patients with pulmonary mycobacteriosis had a history of tuberculosis more frequently than those with extrapulmonary forms.
Conclusion: These findings highlight the importance of the differential diagnosis between M. tuberculosis complex species and non-tuberculous mycobacteria since the latter are genetically resistant to conventional antituberculosis drugs.

Downloads

Download data is not yet available.
  • Claudia Llerena Grupo de Micobacterias, Laboratorio Nacional de Referencia, Instituto Nacional de Salud, Bogotá, D.C., Colombia
  • Angélica Valbuena Grupo de Micobacterias, Laboratorio Nacional de Referencia, Instituto Nacional de Salud, Bogotá, D.C., Colombia
  • Angie Paola Zabaleta Grupo de Micobacterias, Laboratorio Nacional de Referencia, Instituto Nacional de Salud, Bogotá, D.C., Colombia

References

Farga V, Caminero J. Tuberculosis. Tercera edición. Santiago de Chile: Editorial Mediterráneo; 2011. p. 449-67.

Piersimoni C, Scarparo C. Pulmonary infections associated with non-tuberculous mycobateria in inmmunocompetent patients. Lancent Infect Dis. 2008;8:323-34. https://doi.org/10.1016/S1473-3099(08)70100-2

Katoch V. Infections due to non-tuberculous mycobacteria (NTM). Indian J Med Res. 2004;120:290-304.

Murcia M, Gómez J, Alvarado F, Bustillo J, Deivels E, Gómez B, et al. Prevalence of mycobacterial in HIV positive patients in Bogotá. Rev Colomb Neumol. 2001;13:249-61. https://doi.org/10.1186/1471-2334-1-21

Prevots R, Marras T. Epidemiology of human pulmonary infection with non-tuberculous mycobacteria: A review. Clin Chest Med. 2015;36:13-34. https://doi.org/10.1016/j.ccm.2014.10.002

Simons S, van Ingen J, Hsueh PR, van Hung N, Dekhuijzen PN, Boeree MJ, et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis. 2011;17:343-9. https://doi.org/10.3201/eid170310060

Montúfar F, Madrid C, Montufar M, Aguilar C, Saldarriaga C, Mesa M, et al. Caracterización de pacientes hospitalizados con infecciones causadas por micobacterias no tuberculosas en un hospital de alta complejidad en Colombia. Infectio. 2014;18:135-42. https://doi.org/10.1016/j.infect.2014.06.002

Garzón M, Orjuela D, Naranjo O, Llerena C. Micobacterias no tuberculosas en Colombia, 1995-2003. Inf Quinc Epidemiol Nac. 2005;10:161-76.

García L, Garzón M, Orjuela D, Mejía G, Llerena C. Micobacterias no tuberculosas asociadas a procedimientos de mesoterapia en Colombia, 2004-2007. Infectio. 2010;14:93-6. https//doi:10.1016/S0123-9392(10)70096-5

Castro C, Puerto G, García L, Orjuela D, Llerena C, Garzón M, et al. Identificación molecular de micobacterias no tuberculosas mediante el análisis de los patrones de restricción, Colombia 1995-2005. Biomédica. 2007;27:439-46. https://doi.org/10.7705/biomedica.v27i3.206

Llerena C, Valbuena Y, Zabaleta A, Gómez T. Enfermedad pulmonar causada por complejo Mycobacterium avium y M. abscessus. Acta Médica Colombiana. 2017;42:26-9.

Hain Lifescience. Genotype Mycobacterium CM™. Versión 1.0. Hardwiesenstraße, Nehren: Hain Lifescience; 2011.

Hain Lifescience. Genotype Mycobacterium AS™. Versión 1.0. Hardwiesenstraße, Nehren: Hain Lifescience; 2010.

Russo C, Tortoli E, Menichella D. Evaluation of the new genotype Mycobacterium assay for identification of mycobacterial species. J Clin Microbiol. 2006;44:1769-75. https://doi.org/10.1128/JCM.44.2.334-339.2006

Dirección General de Salud Pública, Ministerio de la Protección Social. Circular externa 058 de 2009. Lineamientos para el manejo programático de tuberculosis y lepra en Colombia. Bogotá: Ministerio de la Protección Social; 2009. Fecha de consulta: 15 de febrero de 2018. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/circular-externa-0007-de-2015.pdf

Ueki S, Martins M, Telles M, Virgilio M, Giampaglia C, Chimara E, et al. Nontuberculous mycobacteria: Species diversity in Sao Paulo state, Brazil. J Bras Patol Med Lab. 2005;41:1-8. https://doi.org/10.1590/S1676-24442005000100003

Prevots D, Shaw P, Strickland D, Jackson L, Raebel M, Blosky M. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182:970-6. https://doi.org/10.1164/rccm.201002-0310OC

Valdivies J, Sánchez R, Fernández S, Osés L. Síndrome de Lady Windermere como causa de tos crónica. A propósito de un caso. An Fac Med. 2015;76:285-7. https://doi.org/10.15381/anales.v76i3.11241

Rivera O, Guevara A, Escalona A, Oliver M, Pérez A, Piquero J, et al. Infecciones en tejidos blandos por micobacterias no tuberculosas secundarias a mesoterapia. ¿Cuánto vale la belleza? Enferm Infecc Microbiol Clin. 2006;24:302-6. https://doi.org/10.1157/13089664

Sanudo A, Vallejo F, Sierra M, Hoyos J, Yepes S, Wolff J, et al. Nontuberculous mycobacteria infection after mesotherapy: Preliminary report of 15 cases. Int J Dermatol. 2007;46:649-53. https://doi.org/10.1111/j.1365-4632.2007.02976.x

Munayco C, Grijalva C, Culqui D, Bolarte J, Suárez-Ognio L, Quispe N, et al. Outbreak of persistent cutaneous abscesses due to Mycobacterium chelonae after mesotherapy sessions, Lima, Perú. Rev Saúde Pública. 2008;42:146-9. https://doi.org/10.1590/S0034-89102008000100020

García X, Barnadas M, Dalmau J, Coll P, Gurguı, Alomar A. Mycobacterium abscessus infection secondary to mesotherapy. Clin Exp Dermatol. 2008;33:658-9. https://doi.org/10.1111/j.1365-2230.2008.02869.x

Carbonne A, Brossier F, Arnaud I, Bougmiza I, Caumes E, Meningaud J, et al. Outbreak of nontuberculous mycobacterial subcutaneous infections related to multiple mesotherapy injections. J Clin Microbiol. 2009;47:1961-4. https://doi.org/10.1128/JCM.00196-09

Wu U, Holland S. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;8:968-80. https://doi.org/10.1016/S1473-3099(15)00089-4

Bustamante J, Boisson-Dupuisa S, Abel L, Casanova J. Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014;26:454-70. https://doi.org/10.1016/j.smim.2014.09.008

Osorio J, Álvarez D, Barreto J, Casanova M, Vargas H, Giraldo G, et al. Infecciones pulmonares en pacientes con VIH 20 años después de la terapia antiretroviral combinada. ¿Qué ha cambiado? Infectio. 2015;20:180-9. https//doi.org/10.1016/j.infect.2015.08.002

Barnes A, Rojo S, Moretto H. Prevalencia de micobacteriosis y de tuberculosis en pacientes de un hospital de referencia de la provincia de Córdoba. Rev Argent Microbiol. 2004;36:170-3.

Telenti A, Marchesi F, Bals M, Bally F, Bodmer T. Rapid identification of Mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31:175-8.

Tobler N, Pfunder M, Herzog K, Frey J, Altwegg M. Rapid detection and species identification of Mycobacterium spp. using real-time PCR and DNA-Microarray. J Microbiol Methods. 2006;66:116-24. https//doi.org/10.1016/j.mimet.2005.10.016

Ng E, Wong M, Poon T. Advances in MALDI mass spectrometry in clinical diagnostic applications. Top Curr Chem. 2014;336:139-75. https://doi.org/10.1007/1282012413

Alcaide F, Palop-Borrás B, Domingo D, Tudó G. Aplicación de la espectrometría de masas en micobacterias. Enferm Infecc Microbiol Clin. 2016;34(Supl.2):31-5. https://doi.org/10.1016/S0213-005X(16)30188-4

Griffith D, Aksamit T, Brown-Elliott B, Catanzaro A, Daley C, Gordin F, et al. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416. https://doi.org/10.1164/rccm.200604-571ST

How to Cite
1.
Llerena C, Valbuena A, Zabaleta AP. Mycobacterioses identified in the National Reference Laboratory of Colombia from 2012 to 2016. biomedica [Internet]. 2018 Aug. 1 [cited 2024 May 18];38(Sup. 2):87-94. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/4143

Some similar items:

Published
2018-08-01

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code